AWM
SRPT icon

Avior Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Avior Wealth Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21
Closed -$2.55K – 2113
2024
Q4 		$2.55K Buy
+21
New +$2.57K ﹤0.01% 2071
2024
Q2 		– Sell
-183
Closed -$23.7K – 3540
2024
Q1 		$23.7K Buy
+183
New +$22.4K ﹤0.01% 1528
2023
Q4 		– Sell
-3,295
Closed -$399K – 1659
2023
Q3 		$399K Buy
3,295
+1,246
+61% +$141K 0.03% 379
2023
Q2 		$235K Sell
2,049
-1,279
-38% -$165K 0.02% 501
2023
Q1 		$459K Hold
3,328
– – 0.03% 369
2022
Q4 		$431K Buy
3,328
+594
+22% +$68.8K 0.03% 337
2022
Q3 		$302K Buy
+2,734
New +$276K 0.03% 383
2021
Q1 		– Sell
-3,611
Closed -$615K – 1134
2020
Q4 		$615K Sell
3,611
-749
-17% -$111K 0.08% 222
2020
Q3 		$612K Buy
4,360
+800
+22% +$122K 0.09% 198
2020
Q2 		$570K Hold
3,560
– – 0.09% 207
2020
Q1 		$348K Buy
3,560
+280
+9% +$32K 0.07% 249
2019
Q4 		$423K Hold
3,280
– – 0.07% 260
2019
Q3 		$247K Buy
3,280
+490
+18% +$57.9K 0.04% 338
2019
Q2 		$424K Hold
2,790
– – 0.08% 235
2019
Q1 		$332K Buy
2,790
+1,180
+73% +$152K 0.07% 259
2018
Q4 		$175K Buy
1,610
+1,010
+168% +$126K 0.04% 334
2018
Q3 		$97K Buy
+600
New +$82K 0.02% 437

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Avior Wealth Management's SRPT Position: Q1 2025 in Review

Avior Wealth Management sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 21 shares — an estimated $2.55K sold.

Avior Wealth Management first reported a position in SRPT in Q3 2018 and held it in 17 quarters. The position peaked at $615K in Q4 2020. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Avior Wealth Management reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 21 Sarepta Therapeutics shares in Q1 2025, an estimated $2.55K.
  • Avior Wealth Management first reported a position in Sarepta Therapeutics in Q3 2018 and held it in 17 quarters.
  • Avior Wealth Management's Sarepta Therapeutics position peaked at $615K in Q4 2020.
  • 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.